Difference between revisions of "Respiratory diseases in Europe"

From Testiwiki
Jump to: navigation, search
m (corrected category setting (my bad...))
(→‎Causality)
Line 13: Line 13:
  
 
=== Causality ===
 
=== Causality ===
 +
 +
* Particles < 2.5 µm
 +
 +
{| border="1"
 +
! Health endpoints
 +
! Risk group fraction
 +
! Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions)
 +
|- valign="top"
 +
| Life expectancy reduction - YOLLchronic
 +
| Adults_30andAbove
 +
| 4,557E-04
 +
|- valign="top"
 +
| New cases of chronic bronchitis (1)
 +
| Adults_27andAbove
 +
| 3,731E-05
 +
|- valign="top"
 +
| Restricted activity days (RADs)
 +
| Adults_15_to_64_years
 +
| 6,061E-02
 +
|- valign="top"
 +
| Work loss days (WLD)
 +
| Adults_15_to_64_years
 +
| 1,391E-02
 +
|- valign="top"
 +
| Minor restricted activity days (MRAD)
 +
| Adults_18_to_64_years
 +
| 3,693E-02
 +
|- valign="top"
 +
|}
 +
 +
 +
* Particles < 10 µm
 +
 +
{| border="1"
 +
! Health endpoints
 +
! Risk group fraction
 +
! Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions)
 +
|- valign="top"
 +
| Respiratory hospital admissions
 +
| Total
 +
| 7,030E-06
 +
|- valign="top"
 +
| Cardiac hospital admissions
 +
| Total
 +
| 4,340E-06
 +
|- valign="top"
 +
| Medication use / bronchodilator use
 +
| Children_PEACE_criteria_for_asthma_5_to_14
 +
| 4,032E-04
 +
|- valign="top"
 +
| Medication use / bronchodilator use
 +
| Adults_20andAbove_asthmatics
 +
| 2,234E-02
 +
|- valign="top"
 +
| Lower respiratory symptoms (adult)
 +
| Adults_symptomatic_adults
 +
| 3,185E-02
 +
|- valign="top"
 +
| Lower respiratory symptoms (child)
 +
| Children_5_to_14_years
 +
| 2,083E-02
 +
|- valign="top"
 +
|}
 +
 +
* Ozone
 +
 +
{| border="1"
 +
! Health endpoints
 +
! Risk group fraction
 +
! Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions)
 +
|- valign="top"
 +
| Increased mortality risk
 +
| Total
 +
| 8,219E-07
 +
|- valign="top"
 +
| Respiratory hospital admissions
 +
| Elderly_65andAbove
 +
| 5,411E-09
 +
|- valign="top"
 +
| MRAD
 +
| Adults_18_to_64_years
 +
| 2,016E-05
 +
|- valign="top"
 +
| Medication use / bronchodilator use
 +
| Adults_20andAbove_asthmatics
 +
| 4,900E-05
 +
|- valign="top"
 +
| LRS excluding cough
 +
| Children_5_to_14_years
 +
| 4,910E-06
 +
|- valign="top"
 +
| Cough days
 +
| Children_5_to_14_years
 +
| 2,854E-05
 +
|- valign="top"
 +
|}
 +
 +
(Please notice that these data are newly developed by NEEDS and not yet published!!!!!)
 +
 +
 
List of parents:
 
List of parents:
 
* [[Air pollution exposure]]
 
* [[Air pollution exposure]]

Revision as of 13:43, 14 March 2007

If you need help about filling in a variable, press the Preview button and open the link at the end of this paragraph in a new window. Otherwise, just delete this paragraph and start writing.

Scope
Respiratory morbidity/mortality describes

Description

References

  • Anderson HR et al. Meta-analysis of time-series and panel studies of Particulate Matter (PM) and Ozone (O3): report of a WHO task group. WHO Regional Office for Europe, 2004. Accessed 11 November 2005.

Definition

Causality

  • Particles < 2.5 µm
Health endpoints Risk group fraction Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions)
Life expectancy reduction - YOLLchronic Adults_30andAbove 4,557E-04
New cases of chronic bronchitis (1) Adults_27andAbove 3,731E-05
Restricted activity days (RADs) Adults_15_to_64_years 6,061E-02
Work loss days (WLD) Adults_15_to_64_years 1,391E-02
Minor restricted activity days (MRAD) Adults_18_to_64_years 3,693E-02


  • Particles < 10 µm
Health endpoints Risk group fraction Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions)
Respiratory hospital admissions Total 7,030E-06
Cardiac hospital admissions Total 4,340E-06
Medication use / bronchodilator use Children_PEACE_criteria_for_asthma_5_to_14 4,032E-04
Medication use / bronchodilator use Adults_20andAbove_asthmatics 2,234E-02
Lower respiratory symptoms (adult) Adults_symptomatic_adults 3,185E-02
Lower respiratory symptoms (child) Children_5_to_14_years 2,083E-02
  • Ozone
Health endpoints Risk group fraction Factor to be multiplied by accumulated exposure to get the cases of physical impacts (1 per t of emissions)
Increased mortality risk Total 8,219E-07
Respiratory hospital admissions Elderly_65andAbove 5,411E-09
MRAD Adults_18_to_64_years 2,016E-05
Medication use / bronchodilator use Adults_20andAbove_asthmatics 4,900E-05
LRS excluding cough Children_5_to_14_years 4,910E-06
Cough days Children_5_to_14_years 2,854E-05

(Please notice that these data are newly developed by NEEDS and not yet published!!!!!)


List of parents:

Data

Formula

PM10 and respiratory mortality (all ages): A relative risk of PM10 per 10 microgram/m3 and respiratory mortality of 1.013 (1.005-1.020) was chosen

Ozone (8-hour) and respiratory mortality (all ages): A relative risk of Ozone per 10 microgram/m3 and respiratory mortality of 1.000 (0.996-1.005) was chosen


Unit

Result

Retrieved from "http://www.opasnet.org/testiwiki/index.php?title=Respiratory_diseases_in_Europe&oldid=13251"